Mutations in RNA splicing machinery in human cancers

New England Journal of Medicine

Volumn 365, Issue 26, 2011, Pages 2534-2535

  Ebert, Benjamin ^a   Bernard, Olivier A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CD9 ANTIGEN; NOTCH RECEPTOR; WNT PROTEIN; DNA;

ATM GENE; B LYMPHOCYTE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMOSOME 11Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; DNA DAMAGE; DNA SEQUENCE; EDITORIAL; EPIGENETICS; GENE IDENTIFICATION; GENOMICS; HETEROZYGOSITY; HUMAN; INFLAMMATION; LEUKEMOGENESIS; MISSENSE MUTATION; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; ONCOGENE; PRIORITY JOURNAL; RNA SPLICING; SF3B1 GENE; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TET2 GENE; GENETICS; MUTATION; NOTE; SPLICEOSOME;

DNA, NEOPLASM; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTATION; SPLICEOSOMES;

EID: 84855369385     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1111584     Document Type: Editorial

References (10)

1. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011;365:2497-506.
2. Fabbri G, Rasi S, Rossi D, et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011;208:1389-401.
3. Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011;475:101-5.
4. Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011;365:1384-95.
5. Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478:64-9.
6. Isono K, Mizutani-Koseki Y, Komori T, Schmidt-Zachmann MS, Koseki H. Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1. Genes Dev 2005;19:536-41. (Pubitemid 40314986)
7. Quivoron C, Couronné L, Della Valle V, et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011;20:25-38.
8. Kikushige Y, Ishikawa F, Miyamoto T, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 2011;20:246-59.
9. Kaida D, Motoyoshi H, Tashiro E, et al. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 2007;3:576-83. (Pubitemid 47294395)
10. Yokoi A, Kotake Y, Takahashi K, et al. Biological validation that SF3b is a target of the antitumor macrolide pladienolide. FEBS J 2011;278:4870-80.